| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 166 |
| 1 | DEXAMETHASONE 1.5 MG | 166 |
| 2 | CYCLOPHOSPHAMIDE | 130 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 130 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 130 |
| 5 | LENALIDOMIDE | 110 |
| 6 | PANTOPRAZOLE | 109 |
| 7 | RITUXIMAB | 100 |
| 8 | METHOTREXATE SODIUM | 84 |
| 9 | ALLOPURINOL | 79 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEDOSIRAN | 1 | 0.0833 |
| 1 | ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE | 1 | 0.0086 |
| 2 | ISATUXIMAB | 32 | 0.0055 |
| 3 | ELOTUZUMAB | 27 | 0.0052 |
| 4 | IDARUBICIN HYDROCHLORIDE | 6 | 0.0052 |
| 5 | AMMONIUM CHLORIDE | 1 | 0.0040 |
| 6 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| 7 | ERAVACYCLINE | 1 | 0.0034 |
| 8 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 9 | IDURSULFASE | 11 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 299 |
| 1 | Alkylating Drug [EPC] | 144 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 137 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 135 |
| 4 | Thalidomide Analog [EPC] | 134 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 113 |
| 6 | Platinum-based Drug [EPC] | 96 |
| 7 | Proteasome Inhibitor [EPC] | 83 |
| 8 | Microtubule Inhibitor [EPC] | 82 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 80 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 32 | 0.0055 |
| 1 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 27 | 0.0052 |
| 2 | CD22-directed Immunoconjugate [EPC] | 6 | 0.0020 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 23 | 0.0018 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 7 | 0.0011 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 13 | 0.0010 |
| 7 | CD30-directed Immunoconjugate [EPC] | 10 | 0.0010 |
| 8 | Penem Antibacterial [EPC] | 29 | 0.0008 |
| 9 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |